Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
House dust mite extract is a biological preparation containing allergens derived from dust mites, such as *Dermatophagoides pteronyssinus* and *Dermatophagoides farinae*. In the context of clinical research at China Medical University Hospital, this crude extract is utilized as an experimental stimulant to investigate the mechanisms of allergic inflammation. Specifically, it is used to stimulate peripheral blood mononuclear cells (PBMCs) from allergic and non-allergic subjects to study the activation of inflammasomes. The research aims to determine how house dust mite (HDM) exposure triggers these pathways and contributes to corticosteroid resistance, which is a significant clinical challenge in the management of chronic allergic conditions like asthma and allergic rhinitis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on house dust mite extract.